Lawmakers seek GAO study of federal regenerative medicine efforts
This article was originally published in Clinica
Executive Summary
A bipartisan group of senators have asked the Government Accountability Office (GAO) to assess the federal government's activities related to regenerative medicine and if those efforts are being appropriately coordinated.